H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Census population 633,104. Tennessee Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Memphis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Memphis storefront.
PRP Injections & Treatment Systems in Memphis, TN for clinics & physicians. Add PRP injections to your pra… Compliance support & pricing — contact Hawk Medical.
14.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Population 633,104. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JJ documentation are ready before the first application of prp injections.
National PRP Injections & Treatment Systems notes (how the product actually works)14.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 633,104 residents will still mix those payers. CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Memphis trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 17.6% of adults — 5.6 points above the U.S. 12% figure. Obesity is 42.1%; arthritis is 27.3%. That is place-level BRFSS modeling, not a clinic census and not a Memphis trial.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Palmetto GBA LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Tennessee.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Tennessee audit trail stays clean.
Bring specialty, monthly joint / regenerative volume, and whether you bill JJ FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 17.6% diabetes and 27.3% arthritis for Memphis — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Memphis, TN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Memphis is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Memphis — 5.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Tennessee Part B wound biologics follow this contractor (siblings: AL, GA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Memphis. Useful for joint-program math; still needs a diagnosis and privileging.
No Memphis storefront. Joe Bradley is an active practice owner. prp injections stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.